LRRK2 G2019S variant is associated with transcriptional changes in Parkinson's disease human myeloid cells under proinflammatory environment.
Navarro E, Efthymiou AG, Parks M, Riboldi GM, Vialle RA, Udine E, Muller BZ, Humphrey J, Allan A, Argyrou CC, Lopes KP, Münch A, Raymond D, Sachdev R, Shanker VL, Miravite J, Katsnelson V, Leaver K, Frucht S, Bressman SB, Marcora E, Saunders-Pullman R, Goate A, Raj T.
Navarro E, et al. Among authors: katsnelson v.
bioRxiv [Preprint]. 2024 May 31:2024.05.27.594821. doi: 10.1101/2024.05.27.594821.
bioRxiv. 2024.
PMID: 38854101
Free PMC article.
Preprint.